ReviewSage open pathology
Functional Dyspepsia: An Updated Review of Pathophysiology, Epidemiology, Clinical Manifestations, and International Management Guidelines.
Review in Sage open pathology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Functional dyspepsia (FD) is a prevalent yet challenging gastrointestinal disorder described as a group of upper gastrointestinal symptoms such as epigastric pain or burning, bloating, belching among many others, in the absence of an identifiable organic etiology. Its diagnosis is established according to the Rome IV criteria, which define the disorder by bothersome postprandial fullness, early satiety, epigastric pain and/or epigastric burning present for the last 3 months, with symptom onset at least 6 months before diagnosis. Despite its benign nature, functional dyspepsia can considerably affect patients' quality of life and constitutes a significant burden on healthcare systems worldwide, as it is estimated to affect over 20% of the population. FD can be subdivided into the three following subtypes - postprandial distress syndrome (PDS), epigastric pain syndrome (EPS) and a constellation of both - based on symptoms' pattern. Objectives: This article provides a comprehensive overview of the epidemiology, pathophysiology, subtypes, clinical presentation as well as management strategies of functional dyspepsia. Understanding these aspects is crucial for improving diagnosis and applying effective treatment strategies for patients with functional dyspepsia. Design: Narrative literature-based review. Methods: We conducted a search of PubMed/MEDLINE, Embase, and Google Scholar for publications from January 2010 to March 2025, including clinical studies, reviews, and international guidelines related to functional dyspepsia. Results: The pathophysiology of functional dyspepsia remains poorly understood, largely due to its multifactorial nature. Several factors at both the macroscopic and microscopic level have been implicated in the pathogenesis of this disorder such as altered gastrointestinal motility, impaired barrier function, altered gut-brain axis, inflammation as well as psychological factors. Several clinical guidelines, both European and American, have been developed to guide the diagnosis of functional dyspepsia and its management with the primary goal of symptom control. Conclusion: Functional dyspepsia remains a complex disorder due its diverse clinical features and multifactorial etiology. A patient-centered approach and management based on recent guidlines are essential for effective management of this condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.